We have investigated the phosphorylation state of the human cytomegalovirus 86-kDa immediate-early (IE) protein IEP86 from transfected and infected cells. We show that multiple domains of IEP86 are phosphorylated by cellular kinases, both in vitro and in vivo. Our data suggest that serum-inducible kinases play a significant role in cell-mediated IE protein phosphorylation and that a member of the mitogen-activated protein (MAP) kinase (MAPK) family, extracellular regulated kinase 2 (ERK2), phosphorylates several domains of IEP86 in vitro. Alanine substitution mutagenesis was performed on specific serines or threonines (T 27 , S 144 , T 233 /S 234 , and T 555 ) found in consensus MAP kinase motifs. Analysis of these mutations showed that T 27 and T 233 /S 234 are the major sites for serum-inducible kinases and are the major ERK2 sites in vitro. S 144 appeared to be phosphorylated in a serum-independent manner in vitro. All of the mutations except T 555 eliminated specific phosphorylation in vivo. In transient transfection analyses, IEP86 isoforms containing mutations in S 144 and, especially, T 233 /S 234 displayed increased transcriptional activation relative to the wild type, suggesting that phosphorylation at these sites in wild-type IEP86 may result in reduction of its transcriptional activation ability.
The major immediate-early (MIE) gene of human cytomegalovirus (HCMV) gives rise to several transcripts through alternative splicing and polyadenylation of the primary transcript (1, 32, 40, 81, 82, 84, 85, 87) (Fig. 1) . Two of these transcripts, expressed with immediate-early (IE) kinetics, encode nuclear phosphoproteins with observed molecular masses of 72 kDa (IEP72; IE1 491aa ) and 86 kDa (IEP86; IE2 579aa ). IEP72 and IEP86 function in the temporal transcriptional activation of HCMV early and late viral genes (38, 44, 45, 51, 79, 80) . In addition, these proteins are promiscuous transcriptional activators of many cellular genes (8, 29-32, 45, 48, 57, 83, 95, 96) . In previous studies, our laboratory and others (9, 11, 20, 30, 42, 45, 47, 49, 50, 74, 77) have shown that activation mediated by IEP86 is correlated with protein-protein interactions involving IEP86 with upstream-bound transcription factors as well as with the basal transcription complex, in particular the TFIID complex. In this regard, both IEP72 and IEP86 appear to function as integral components of the TFIID complex in a manner similarly to TATA-binding protein (TBP)-associated factors (TAFs) (50) . Such a role is consistent with the observed promiscuous transcriptional activation mentioned above.
The potential role of phosphorylation in the function of the HCMV IE proteins has not been widely addressed. Studies involving a variety of transcription factors have shown that phosphorylation is a major mechanism for controlling the factors' activities. For example, phosphorylation can affect the ability of transcription factors to bind DNA, to interact with coactivators, and to homodimerize and can alter intramolecular conformation (reviewed in reference 39). In this regard, the herpes simplex virus type 1 (HSV-1) transactivator ICP4, which shows some functional similarities with IEP86, is posttranslationally modified by phosphorylation during the course of infection (53, 61, 90, 92, 93) . This may alter the functional properties of ICP4 at different phases of the viral life cycle (76, 92) . Similarly, the functions of IEP86 may be affected by its phosphorylation state (32, 67, 72, 77) .
One means by which many factors undergo site-specific phosphorylation or dephosphorylation is in response to signal transduction pathways activated by extracellular signals such as growth factors, cytokines, or stress. Kinase pathways activated by such signaling mediate nuclear translocation of members of a family of serine/threonine kinases known as the mitogenactivated protein kinases (MAPKs). Following activation and nuclear entry, the MAPKs can affect the activities of various cellular transcription factors such as c-Jun (17, 70) , Elk-1 (89) , and c-Myc (15, 27) . Other serine/threonine kinases such as cyclic AMP-dependent protein kinase (PKA) and protein kinase C (PKC) also display altered activities as a result of second messenger molecules induced by extracellular signals. Activation of PKA-and PKC-mediated phosphorylation pathways has been shown to affect the activity of cellular transcription factors such as CREB (25) and c-Jun (6), respectively. In addition, PKA appears to play a role in the phosphorylation of HSV-1 ICP4 (92, 93) . In this manner, HSV-1 may respond to changes in the extracellular milieu via alterations in the phosphorylation state of ICP4, potentially affecting the balance between latent and lytic infection (76, 92) .
In this study, we investigated the phosphorylation state of the HCMV IE proteins, with emphasis on IEP86. We show that multiple domains of IEP86 are phosphorylated by cellular kinases, both in vitro and in vivo. Our data suggest that seruminducible kinases play a significant role in cell-mediated IE protein phosphorylation. We show that a member of the MAPK family, extracellular regulated kinase 2 (ERK2), phosphorylates several domains of IEP86 in vitro. Alanine substitution mutagenesis of specific serines or threonines found in consensus MAPK motifs of IEP86 was observed to prevent ERK2-mediated phosphorylation of these motifs in vitro, and eliminate specific phosphorylation in vivo, indicating that Qiagen Ni-nitrilotriacetic acid resin as described by the manufacturer. Eluates were dialyzed into 10 mM Tris (pH 8.0)-5% glycerol. Equivalent amounts of each tagged protein were used for experiments, with quantitation by Bradford analysis as well as by staining gels with silver, Coomassie blue, or Sypro red.
HCMV infections. The Towne strain of HCMV (a generous gift of Teresa Compton) was propagated in primary human foreskin fibroblasts. Experimental infections were performed at a multiplicity of infection of 1. The virus inoculum was allowed to adsorb to U-373 MG cells for 1.5 to 2 h at 37°C in HG-DMEM without serum, after which the medium was replaced with HG-DMEM supplemented with 2% FCS.
Transfections. U-373 MG cells were grown in 100-mm-diameter tissue culture dishes for [ 32 P]orthophosphate labeling studies and in 60-mm-diameter dishes for luciferase reporter assay studies. Cells at 60 to 75% confluence were transfected by the calcium phosphate method as previously described (26) . As thoroughly described in reference 26, we do not use internal control plasmids for transfection standardization since the viral activator proteins often affect reporter expression from these plasmids; hence we repeat our transfections multiple times, using different cells and different plasmid preparations.
For 32 P labeling, the cells were transfected with 10 g of pRSV86-based plasmids, expressing either WT or mutant IEP86 cDNAs, or the pRSV3/BglII control plasmid. Total transfected DNA was bought to 20 g by using pGEM4. For reporter assay studies, cells were transfected with 3 g of pRSV86-based plasmids and 2 g of luciferase reporter plasmid, and total DNA was brought to 10 g by using pGEM4. At 12 to 16 h posttransfection, cells were washed with phosphate-buffered saline, treated with 15% glycerol (26, 49) for 1 min, and then washed twice with phosphate-buffered saline, followed by addition of fresh medium to the cells. Approximately 44 to 48 h after transfection, the cells were either labeled with [ 32 P]orthophosphate (see below) or harvested for reporter assays.
Luciferase reporter assays were performed on transfected cell extracts harvested as instructed by the manufacturer (Promega). Luciferase activity of equal amounts of cell extracts (as determined by Bradford analysis) was measured in a Berthold 9501 Lumat luminometer.
In vivo labeling, harvest, and immunoprecipitation. Cell labeling and harvest were performed as previously described (75) . Prior to the addition of label, cells were rinsed once in Tris-buffered saline and once in phosphate-free HG-DMEM (Gibco). Cells were then labeled for 4 to 5 h at 37°C with 0.4 mCi of [ 32 P]orthophosphate (Amersham) per ml in phosphate-free HG-DMEM supplemented with either 2% (infections) or 5% (transfections) dialyzed FCS. Parallel unlabeled samples were treated in exactly the same fashion except for lack of 32 P addition. At harvest, cells were rinsed twice with ice-cold Tris-buffered saline and then lysed in radioimmunoprecipitation assay (RIPA) buffer containing protease and phosphatase inhibitors (1 g of leupeptin per ml, 0.5 mM N␣-p-tosyl-L-lysine chloromethylketone, 0.8 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, (DTT), 2.5 g of aprotinin per ml, 10 mM sodium fluoride, 10 M sodium orthovanadate). Lysates were clarified by addition of Pansorbin cells (Calbiochem) prior to centrifugation at 15,000 rpm for 30 min. Equal counts of clarified lysates (1.5 ϫ 10 9 to 2.0 ϫ 10 9 cpm) or equal amounts of total protein (1.5 to 2.0 mg of unlabeled samples) were subjected to overnight incubation with 1 g of monoclonal antibody (MAb) 810 (Chemicon), which recognizes the amino terminus common to both IEP72 and IEP86. During the last hour of incubation, 75 l of protein A-coated agarose beads (33% [vol/vol] in RIPA buffer; Gibco) was added to precipitate antibody-antigen complexes. The immunoprecipitates were washed three times in RIPA buffer, boiled in 1ϫ Laemmli sample buffer (46) , and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
32 P-labeled lanes were fixed in 25% isopropanol-10% acetic acid, dried, and subjected to autoradiography. Unlabeled lanes were transferred to nitrocellulose and then probed with rabbit antisera directed against the amino terminus common to both IEP72 and IEP86 (custom produced by Cocalico Biologicals Inc.) as the primary probe and either 125 I-conjugated donkey antirabbit immunoglobulin G (Amersham) or horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (Cappel) as the secondary probe. Washed blots were either air dried and autoradiographed ( 125 I) or treated with enhanced chemiluminescence reagent (Amersham) and autoradiographed. Where indicated, bands were quantified with a Molecular Dynamics PhosphorImager.
Tryptic phosphopeptide mapping. Immunoprecipitated, gel-purified 32 P-labeled proteins were analyzed by tryptic mapping as previously described (5), using modified trypsin, sequencing grade (Boehringer Mannheim). The peptides were spotted on cellulose thin-layer chromatography (TLC) plates (EM Scientific) and resolved in one dimension by electrophoresis at pH 1.9 and in the second dimension by ascending TLC in phosphochromatography buffer (5) .
In vitro phosphorylation assays. For the preparation of serum-starved wholecell extracts (WCE), U-373 MG cells were incubated in low serum (0 or 0.5%) for 48 to 72 h prior to extract preparation. For the preparation of serumstimulated WCE, cells were treated identically except for the addition of medium containing 10% FCS for 15 min prior to extract preparation. Extracts were prepared as previously described (34) .
WCE kinase assays were performed by incubating 250 g of either serumstarved or serum-stimulated WCE with purified, bacterially produced IE protein substrates (GST fusion substrates immobilized on glutathione beads) in the presence of 100 l of kinase buffer B (20 . The reaction mixes were incubated for 30 min with rocking at room temperature. We note that in some experiments the glutathione beads were not added until after the WCE reactions were complete; this resulted in reduction of some background bands. The GST fusion proteins on beads were washed three times with 1 ml of NETN (49) supplemented with protease and phosphatase inhibitors (see above) before boiling in Laemmli sample buffer (46) and separation by SDS-PAGE. Gels were stained with Coomassie blue and dried prior to autoradiography.
WCE kinase assays on His-tagged IEP86 were performed as above, using purified His-tagged IEP86 in solution. To repurify His-tagged substrates from the completed reactions, 10% SDS was added to the reaction mixes to a final concentration of 0.2%. Reaction mixes were incubated at 50°C for 5 min, chilled on ice, and then spun in a microcentrifuge for 5 min at 4°C. Supernatants were transferred to tubes containing 500 l of RIPA buffer (supplemented with antiproteases and antiphosphatases as described above), 45 l of protein Acoated agarose beads (33% [vol/vol] in RIPA buffer), and 1 g of MAb 810. Tubes were incubated at 4°C for 60 to 75 min with rocking. Beads were pelleted by microcentrifugation, washed twice with 1 ml of RIPA buffer, boiled in Laemmli buffer, and separated by SDS-PAGE. Gels were stained with Coomassie blue and dried prior to autoradiography.
The IE substrates were also subjected to in vitro phosphorylation using purified recombinant mouse or rat ERK2 (5 and 60 U/l, respectively; Calbiochem 
RESULTS
The IE proteins are phosphorylated by cellular kinases in vivo. Figure 1 shows the map of the HCMV MIE gene. IEP72 and IEP86 contain the identical 85 amino acids at their N termini, derived from two common exons in the IE-1 region. The remainder of the IEP72-encoding transcript is derived entirely from the IE-1 region, giving rise to a 491-residue protein. The remainder of the IEP86-encoding transcript results from a splice into the IE-2 region, producing a distinct carboxy terminus and a total size of 579 amino acids (56, 67, 81, 84) .
In a variety of experiments (not shown), we have noted that the migration of IEP86 on denaturing polyacrylamide gels is variable depending on the source of its production. For example, IEP86 produced in human cells migrates significantly more slowly on SDS-PAGE than IEP86 produced in bacteria or rabbit reticulocyte lysates. This suggests differences in posttranslational processing events specific to each source. Such processing appears to be extensive since the observed molecular mass of IEP86 on SDS-PAGE, 82 to 86 kDa, differs markedly from the predicted molecular mass of 64 kDa. In addition to several predicted N-linked glycosylation sites on IEP86, there are a total of over 100 serines, threonines, and tyrosines which could be targets for phosphorylation by protein kinases.
To determine the contributions of cellular, virally encoded, or virally induced kinases to the posttranslational modification of IEP86, we isolated IEP86 from U-373 MG cells which had been (i) transiently transfected with a plasmid which expressed IEP86 from a cDNA or (ii) infected with the Towne strain of HCMV. Cells were labeled for 4 to 5 h with [
32 P]orthophosphate prior to harvest at 48 h posttransfection or postinfection. Labeled WCE or similar extracts prepared from unlabeled cells were immunoprecipitated with MAb 810, which precipitates both IEP86 and IEP72 (see Materials and Methods). After the washed immunoprecipitates were separated on SDS-PAGE, relative phosphorylation was detected by autoradiography (Fig. 2) . Extracts from mock-infected cells gave rise to no specific bands at the expected migration position for either IEP72 or IEP86. As previously observed (22, 32, 60, 69, 72) , both IEP72 and IEP86 derived from infected cells were phosphorylated. Western analysis of unlabeled samples prepared in parallel from infected cells demonstrated that IEP72 was consistently expressed at levels 10-to 20-fold higher than levels of IEP86 (not shown). This largely explains the difference in relative intensities of phosphorylation. IEP86 produced from a cDNA in transiently transfected cells was significantly phosphorylated. Hence, cellular kinases are capable of phosphorylating IEP86 independent of viral infection.
The corresponding unlabeled samples were transferred to nitrocellulose, and relative IE protein expression was determined via Western blotting using an 125 I-labeled secondary antibody (not shown). Appropriate bands were quantified with a Molecular Dynamics PhosphorImager. Specific activity was determined by normalizing 32 P intensity to 125 I intensity for each sample. These data (not shown) indicated that the specific activities of IEP86 isolated from transfected cells and from infected cells were approximately equal at the 48-h time point.
Phosphoamino acid analysis revealed that serine and threonine are the only detectably phosphorylated amino acids in IEP86 produced in either transfected or infected cells (not shown).
Mapping the phosphorylation pattern of IEP86. To map the actual phosphorylation patterns for IEP86, 32 P-labeled bands were excised from the gels, eluted, and subjected to tryptic digestion and two-dimensional phosphopeptide analysis on TLC plates (5), followed by autoradiography. Figure 3A shows the tryptic phosphopeptides for IEP86 isolated from infected cells; Fig. 3B shows the tryptic phosphopeptides for IEP86 isolated from cDNA-transfected cells where no other viral gene products were present. Schematic diagrams of the phosphopeptide patterns are shown at the bottom of each panel. For reference, we have assigned letter designations to only those peptides which, in the course of this study, showed differences between transfected and infected cells or were affected by specific mutations in IEP86. The results indicate that 32 P]orthophosphate from 44 to 48 h postinfection or transfection, just prior to WCE preparation. The extracts were immunoprecipitated with MAb 810, which recognizes the shared amino-terminal end of the IE proteins. Immunoprecipitated complexes were subjected to SDS-PAGE followed by autoradiography to detect phosphorylated proteins. Bands migrating at the expected positions for IEP72 and IEP86 are indicated.
IEP86 is phosphorylated at multiple sites under both transfection and infection conditions.
Comparing the major phosphopeptides, the most significant differences between IEP86 from transfected and infected cells were phosphopeptides A/AЈ and D/DЈ. Each of these doublets most likely represents the same phosphopeptide containing different numbers of phosphorylated residues, with the more phosphorylated forms showing decreased migration in both the electrophoresis and chromatography dimensions (5). Infectedcell-derived IEP86 displayed only the more phosphorylated form (AЈ) of peptide A/AЈ, whereas transfected-cell-derived IEP86 usually displayed significant amounts of the less phosphorylated form (A) as well. In large part, the patterns of major phosphopeptides from transfected and infected cells are very similar, suggesting that phosphorylation of IEP86 is mediated largely by cellular kinases at this time point of infection (48 h postinfection).
The similarity of the phosphopeptide patterns produced by infected-cell-and transfected-cell-derived IEP86 was confirmed by performing mixing experiments in which tryptic digests of transfected-cell IEP86 were mixed with digests of infected-cell-derived IEP86. All of the major phosphopeptide species derived from each individual source (those lettered in the diagrams in Fig. 3 ), as well as most of the minor phosphopeptide species, migrated in a completely juxtaposable manner (not shown).
In vitro phosphorylation of IEP86 by serum-starved and serum-stimulated WCE. To examine which cellular kinases play a role in IEP86 phosphorylation, we used an in vitro assay in which WCE prepared from U-373 MG cells were incubated with bacterially produced IEP86 substrates and [␥-32 P]ATP (34, 36) . The activities of various kinases in the cell extracts were manipulated by altering the growth conditions before extract preparation. Serum starvation of cells in culture deprives the cells of growth factors and signaling molecules required for continued progression through the cell cycle, causing the cells to arrest in G 0 (62, 66) . Restimulation with serum leads to transient activation of signaling cascades within the cell. Many of the kinases present in these cascades are dependent on stimulation by c-ras (33, 65) . One downstream target of ras is the MAPK family, consisting of serine/threonine protein kinases which translocate into the nucleus upon phosphorylation of conserved TXY motifs (12) . To assess the contribution of serum-inducible kinases to the phosphorylation of IEP86, extracts were prepared either from U-373 MG cells which had been serum starved for 48 to 72 hours or from cells which were starved and then stimulated with 10% serum for 15 min prior to harvest. Preliminary experiments (not shown) had indicated that maximal MAPK activation, as judged by the levels of activated ERK1 and ERK2, occurred 15 min after serum stimulation.
Extracts prepared from starved or stimulated cells, or extract buffer alone, were incubated with [␥-32 P]ATP and bacterially produced and purified histidine-tagged IEP86. Figure 4 shows that WT IEP86 incubated in extract buffer alone (lane B) was not phosphorylated, indicating that the bacterially produced IEP86 has no autophosphorylation activity under these conditions. In contrast, WT IEP86 incubated with either the serumstarved or serum-stimulated extracts was significantly phosphorylated, indicating that cellular kinases present in the extracts can phosphorylate IEP86 in vitro. WT IEP86 treated with stimulated extracts exhibited more intense phosphorylation than WT IEP86 treated with starved extracts, suggesting that kinases activated by serum stimulation contribute to the greater phosphorylation of IEP86.
Gel-purified IEP86 was subjected to tryptic phosphopeptide FIG. 3 . Tryptic phosphopeptide patterns produced by IEP86 isolated from infected and transfected cells are similar. IEP86 derived from HCMV-infected (A) and cDNA-transfected (B) cells was eluted from excised gel slices and subjected to tryptic digestion and phosphopeptide mapping as described in Materials and Methods. Electrophoresis was performed at pH 1.9, and TLC was conducted in phosphochromatography buffer (5) . Typical autoradiograms of the tryptic phosphopeptides are shown at the top. The experiments were repeated several times; despite variations from sample to sample in total radioactivity spotted and differences in overall migration in each dimension, the basic patterns were quite reproducible. In the schematic below each autoradiogram, major phosphopeptides are labeled with letters for reference.
mapping. Autoradiography showed that the phosphopeptide maps of IEP86 phosphorylated by WCE (Fig. 5) were similar to the phosphopeptide maps of IEP86 isolated from transfected and infected U-373 MG cells (Fig. 3) . As described earlier, the identities of these peptides were confirmed by experiments where tryptic peptides from each source were mixed and analyzed (not shown). Tryptic phosphopeptides C, D, and E appeared to be more intensely labeled in samples which had been treated with serum-stimulated extracts. Furthermore, tryptic peptides A and AЈ have altered mobilities depending on the extract used; this effect is somewhat variable. These data suggest that cellular kinases, particularly seruminducible kinases, play a significant role in phosphorylation of IEP86.
Mapping the IEP86 domains phosphorylated in vitro by WCE. To determine which regions of IEP86 are phosphorylated by cellular kinases, bacterially expressed and purified GST fusions to either full-length IEP86 or various exonic and subexonic fragments (Fig. 6) were incubated with serumstarved or serum-stimulated WCE and [␥-
32 P]ATP. The repurified fragments were then displayed on SDS-polyacrylamide gels. The results of these experiments are shown in Fig. 7 . Lanes are denoted by the specific exonic region in the purified GST fusion used (Fig. 6) ; lanes marked 86 indicate the GST fusion with full-length wild-type IEP86. The Ϫ and ϩ signs indicate serum-starved and serum-stimulated extracts, respectively. The black and white dots indicate the migration of the GST fusion proteins as seen after Coomasie blue or Sypro red staining of the gels. Short exposures of the full-length IEP86 lanes (last set of lanes on the right) agree with results in Fig. 4 , showing that serum-stimulated extracts phosphorylate fulllength IEP86 more than starved extracts. Individual IEP86 domains phosphorylated more intensely by serum-stimulated extracts included exonic regions 2/3, 5B, and 6; hence, sites within these regions appear to be targeted by serum-inducible kinases.
The domain most strongly phosphorylated in vitro was region 5C. Although some WCE preparations suggested that phosphorylation of region 5C may be slightly serum inducible, the majority of extracts indicated that phosphorylation was relatively equal by both starved and stimulated extracts. This phosphorylation appeared to localize to both the amino-and carboxy-terminal portions of region 5C, named 5CA and 5CB, respectively. Region 5A was also phosphorylated relatively equally by both starved and stimulated extracts, while the unique region was very weakly phosphorylated in a serumindependent fashion (visible only in longer exposure than shown in Fig. 7) .
We cannot rule out the possibility that other serum-inducible kinases, which had not been induced during the 15- min   FIG. 4 . Full-length WT IEP86, but not mutant IEP86, is phosphorylated in a serum-inducible manner in vitro. Histidine-tagged full-length IEP86 purified from bacterial extracts was incubated with [␥-
32 P]ATP plus extract buffer alone (B) or with WCE prepared from U-373 MG cells which had been either serum starved (Ϫ) or serum stimulated (ϩ) as described in Materials and Methods. His-tagged IEP86 was repurified and subjected to SDS-PAGE. Relative phosphorylation was detected by autoradiography. Mut. IEP86 represents full-length His-tagged IEP86 containing alanine substitution mutations at Thr 27 and Thr 233 / Ser 234 .
FIG. 5. Tryptic phosphopeptide patterns produced by in vitro-phosphorylated IEP86 are similar to those produced by in vivo-phosphorylated IEP86. Histidinetagged IEP86 phosphorylated by serum-starved WCE (Starved) or serum-stimulated WCE (Stimulated) was eluted from excised gel slices and subjected to tryptic digestion and phosphopeptide mapping. The samples in these autoradiograms were not run as far in the electrophoretic dimension as those shown in Fig. 3 . Major phosphopeptides are labeled according to the schematics in Fig. 3 . Phosphopeptides which were phosphorylated more strongly by serum-stimulated extracts are labeled with larger letters (C, D, and E).
FIG. 6.
The exonic regions of IEP86 used in GST fusion proteins for phosphorylation studies. First and last amino acids in exonic regions (ex) are numbered above, with corresponding names at the right. UR represents the unique coding region in IEP86 which differentiates it from IEP55 (Fig. 1) . GST fusions to full-length IEP86 were made with amino acids 1 to 579, as shown at the top. serum stimulation period, play a role in phosphorylating these domains. Figure 8 shows a schematic summary of the in vitro WCE phosphorylation results. Amino acid sequence analysis using the ExPASy PROSITE program, as well as a tabulation of kinase site specificity motifs (64) , detected the several consensus MAPK phosphorylation motifs shown in the diagram. Each of the regions which showed serum-inducible phosphorylation contains a consensus MAPK motif.
Purified ERK2 phosphorylates IEP86 on several domains in vitro. To demonstrate that a MAPK could directly phosphorylate IEP86 in vitro, purified recombinant ERK2 and [␥- 32 P] ATP were incubated with purified bacterially expressed GST fusions to full-length IEP86 or to the various exonic regions. Figure 9 shows that purified ERK2 phosphorylated full-length GST-IEP86 (lane 86). Using the exonic and subexonic IEP86 substrates revealed that the individual domains most efficiently phosphorylated by ERK2 were exonic regions 2/3 (lane 2/3), and 5B (lane 5B). Faint phosphorylation, above a background smear, was reproducibly observed for exonic region 5A (lane 5A). None of the other exonic regions (5C, 5CA, 5CB, unique region, and 6) were significantly phosphorylated by ERK2.
Tryptic phosphopeptide mapping of full-length His-tagged IEP86 phosphorylated by ERK2 in vitro (not shown) indicated that ERK2 phosphorylation gave rise to phosphopeptides which migrate identically to phosphopeptides C and E derived from in vivo-phosphorylated IEP86 (Fig. 3) and from WCEtreated IEP86 (Fig. 5) .
Mutation of predicted MAPK sites in IEP86 reduces seruminducible phosphorylation by WCE and prevents phosphorylation by purified ERK2 in vitro. Several potential MAPK phosphorylation motifs in IEP86 are shown in Fig. 8 ; of particular interest are Thr 27 (PRPET*P) in exon 2/3, Thr 233 /Ser 234 (PRVTS*P) in exon 5B, and Thr 555 (PTET*P) in exon 6, all of which are in domains specifically phosphorylated in vitro in a serum-inducible manner. To determine whether these consensus motifs were utilized, the putative phosphorylated amino acids at positions 27, 233/234, and 555 (marked with asterisks above) were each mutated to alanine (Fig. 8) . In addition, an alanine was substituted for Ser 144 , which lies within a potential MAPK motif that could also be a potent site for PKC and p34 cdc2 /cyclin B (PELS*PRKK). MAPKs may not be involved in phosphorylation of this motif since levels of in vitro phosphorylation of exonic region 5A, containing Ser 144 , were similar in serum-starved and stimulated WCE (Fig. 7) , and region 5A was not phosphorylated efficiently by purified ERK2 in vitro (Fig. 9) . Figure 10 shows the results of in vitro phosphorylation using serum-starved and stimulated extracts with GST fusions to exonic regions containing either WT or mutant MAPK motifs. As previously noted (Fig. 7) and reiterated here (Fig. 10A) , wild-type exonic regions 2/3, 5B, and 6 displayed serum-inducible phosphorylation. When the mutant counterparts were similarly tested, we found that phosphorylation of mutant exonic regions 2/3 (T27A) and 5B (T233A/S234A) was dramatically decreased, compared to the WT region, by both the serumstarved and serum-stimulated extracts (Fig. 10A) . The mutation in exonic region 6 (T555A) had little effect on in vitro phosphorylation by either extract (Fig. 10A) . Thus, the serum- inducible phosphorylation of this region may occur at a site or sites other than Thr 555 .
The substrate containing the mutation in exonic region 5A (S144A) showed no phosphorylation by either the starved or stimulated extracts (Fig. 10B) . Thus, Ser 144 may be the only residue in this exonic region which is phosphorylated by WCE under these conditions.
To confirm that Thr 27 and Thr 233 /Ser 234 were major seruminducible phosphorylation sites in the context of full-length IEP86, both mutations were put into full-length His-tagged IEP86. The purified His-tagged mutant proteins were assayed with serum-starved and serum-stimulated extracts. The results (Fig. 4) show a dramatic decrease in serum-inducible phosphorylation compared to the analogous WT protein.
In additional studies, we used purified ERK2 for in vitro phosphorylation analysis of the T27A and T233A/S234A mutations. Whereas ERK2 efficiently phosphorylated GST fusions with WT exonic regions 2/3 and 5B, phosphorylation of the mutant counterparts was significantly reduced or eliminated (Fig. 10A) .
In summary, the data suggested that much or all of the serum-inducible phosphorylation of IEP86 localizes to Thr 27 , Thr 233 /Ser 234 , and a site(s) in exon 6. The motifs in which these amino acids lie suggest that the kinases primarily responsible for serum-inducible phosphorylation are MAPK family members.
Mutation of MAPK sites affects in vivo phosphorylation of IEP86. To determine whether the various alanine substitution mutations affect in vivo phosphorylation, plasmids expressing full-length IEP86 with the alanine mutations were transiently transfected into U-373 MG cells. Sets of cells were either labeled with [ 32 P]orthophosphate or mock labeled for the last 4 to 5 h before extraction. Western analysis of immunoprecipitated IEP86 from the mock-labeled cells indicated that WT and mutant forms of IEP86 were expressed to similar levels (data not shown). IE proteins immunoprecipitated from labeled extracts were gel purified and subjected to tryptic phosphopeptide mapping (Fig. 11) .
The mutation of Thr 27 resulted in the loss of phosphopeptide E, suggesting that phosphopeptide E represents a predicted tryptic peptide spanning residues 22 to 31 and phosphorylated at Thr 27 . Likewise, mutation of Ser 144 resulted in the loss of phosphopeptide B, suggesting that this spot represented a predicted tryptic peptide spanning residues 117 to 146 and phosphorylated at Ser 144 . Mutation of Thr 233 /Ser 234 had a more complex effect; phosphopeptides D and DЈ were lost, whereas spots A and AЈ were reduced in intensity. Interestingly, on one-dimensional SDS-PAGE analysis, the T233A/ S234A mutation caused a distinct alteration in mobility compared to the other mutants (not shown). Taken together, these observations suggest that phosphorylation of this motif has a pleiotropic effect, possibly altering the conformation of the protein and affecting phosphorylation at more than one site.
The effects of the mutation at Thr 555 were harder to determine. Multiple repetitions indicated that this mutant isoform FIG. 10 . Point mutations at MAPK motifs reduce phosphorylation by U-373 MG WCE in vitro. (A) Purified GST fusions to WT or mutant isoforms of IEP86 serum-inducible phosphorylation domains were tested in the WCE kinase assay as for Fig. 7 . WT versions of exonic regions 2/3 and 5B were phosphorylated more strongly than their mutant counterparts by both the starved (Ϫ) and stimulated (ϩ) extracts. On the far right, results of incubating WT and mutant versions of GST-exon 2/3 and GST-exon 5B with purified ERK2 are shown. (B) Phosphorylation of WT and mutant versions of GST-exon 5A, a serum-independent phosphorylation domain, was compared to phosphorylation of WT and mutant versions of GST-exon 2/3. Sizes are indicated in kilodaltons. FIG. 11 . Point mutations at MAPK motifs affect phosphorylation of specific phosphopeptides in vivo. U-373 MG cells were transiently transfected with plasmids expressing cDNAs for IEP86 containing mutations at specific MAPK motifs (Fig. 8) . Cells were labeled with [ 32 P]orthophosphate, and IEP86 isoforms were immunoprecipitated as described for Fig. 2 . Phosphorylated IEP86 isoforms were eluted from excised gel slices and subjected to tryptic phosphopeptide mapping as for Fig. 3 . Shown are typical autoradiograms for IEP86 mutants T27A, S144A, and T233A/S234A. IEP86 mutant T555A was in most respects identical to the WT protein and is not shown; however, some variability in the A/AЈ region was occasionally seen, as noted in the text. Specific phosphopeptides affected by the mutations are labeled according to the schematics in Fig. 3. was, in large part, identical to WT. However, the tryptic phosphopeptide patterns occasionally indicated that peptide AЈ was missing (not shown). The location of peptides A and AЈ, in proximity to the origin, makes them difficult to resolve; hence, the Thr 555 mutation requires additional study to definitively map its effect.
Overall, the mutational analyses show that point mutations which affected in vitro phosphorylation, using WCE or in some cases purified ERK2, also affected relevant phosphorylation sites in vivo. Phosphopeptide C, which appears to be strongly affected by serum-inducible kinases (Fig. 5 ) in vitro and by purified ERK2 (not shown), has yet to be associated with a specific residue in IEP86.
Effects of alanine substitution mutations on transcriptional activation by IEP86. We next examined whether the mutation of specific phosphorylation sites in IEP86 affected its ability to transcriptionally activate a simple promoter in transient transfection analyses. The promoter tested is taken from the SV40 late promoter and has six copies of the OCT/TEF element in which the OCT sites have been mutated, leaving only functional TEF-1 sites (86). These are situated upstream of the ␤-globin TATA box and the luciferase reporter gene (14, 48) . This promoter has previously been shown to be significantly activated by IEP86 (48, 49) . Figure 12 shows the results of the transfection analysis. The data show that the mutation of S 144 and, especially, T 233 /S 234 caused increased transcriptional activation. Combining the mutations at T 27 , S 144 , and T 233 /S 234 resulted in little more activation than with the T 233 /S 234 mutant alone. These results suggest that phosphorylation of WT IEP86 at S 144 and, especially, T 233 /S 234 may negatively regulate its ability to transcriptionally activate. Schematic summary. Figure 13 schematically summarizes the data presented in this report. T 27 and T 233 /S 234 are the major sites for serum-inducible kinases in vitro and are the major ERK2 sites. The data are correlated with earlier results of protein-protein binding studies between the IE proteins and cellular transcription factors (50) . The major protein-protein interaction domains colocalize with domains phosphorylated in a serum-independent manner.
DISCUSSION
The HCMV IE proteins are the key regulators of the viral life cycle. IE gene expression is required for expression of early and late viral genes and for increased expression of many cellular genes which encode factors necessary for viral replication (35). IEP86 is a major transactivator among the IE gene products. Our lab and others have previously shown that promiscuous transcriptional activation mediated by IEP86 occurs through protein-protein interactions with both upstreambound transcription factors as well as the basal transcription complex where IEP86 and IEP72 perform TAF-like functions (9, 11, 20, 30, 42, 45, 47, 49, 74, 77) . However, this does not appear to be the only mechanism by which IEP86 affects gene expression. IEP86 interacts with a number of cellular regulatory proteins, such as p53 and Rb (28, 41, 58, 78) , and thereby affects gene expression by abrogating the normal functions of these proteins. Hence, IEP86, like SV40 T antigen, interacts with multiple cellular proteins to alter cell and viral gene expression via several distinct mechanisms.
Both IEP72 and IEP86 are phosphoproteins; thus, it is highly likely that posttranslational modification by phosphorylation can modulate or direct the various functions of the IE proteins. It is well documented that phosphorylation affects the ability of transcription factors to interact with other proteins, either by conformational shifts, by changes in local charge, or by altered intracellular localization (reviewed in reference 39). In many cases, the regulation of phosphorylation of transcription factors is the result of extracellular signaling activating intracellular kinase cascades, resulting in altered gene expression (39) .
In the case of HSV-1, phosphorylation of the IE viral transactivator ICP4 by PKA has been suggested to play a role in ICP4's ability to regulate the balance between latent infection and reactivation in neurons (92) . Activation of cellular signal transduction pathways, including cyclic AMP-dependent kinase cascades, may induce reactivation in latently infected neurons in culture (76) . Infection with HSV-1 engineered to contain an ICP4 isoform missing its major phosphorylated region resulted in a virus with reduced ability to replicate in trigeminal ganglia neurons (92) . Correspondingly, WT HSV-1 infection of a cell line deficient in PKA resulted in a much decreased viral replication (92) .
We have begun to determine the role that phosphorylation of the HCMV IE proteins may play in the HCMV life cycle by investigating the phosphorylation pattern of IEP86. Using permissive U-373 MG cells, either infected with HCMV or transiently transfected to produce individual IE proteins, we show that IEP86 is phosphorylated on multiple serine and threonine residues (no tyrosines appear to be phosphorylated). The tryptic phosphopeptide pattern of IEP86 isolated from cDNAtransfected cells (48 h posttransfection) is remarkably similar to that of IEP86 isolated from infected cells 48 h postinfection. This finding suggests that cellular kinases may be primarily responsible for phosphorylation of IEP86 at this time point in infection.
Although a number of viral kinase and phosphatase activities have been associated with HCMV (7, 54, 60, 71) , it is not surprising that cellular kinases may play a major role in phosphorylating HCMV-encoded proteins. In fact, it is possible that a potentially complex interplay may exist between cellular kinase and phosphatase pathways, virally induced signals, and virally encoded kinases and phosphatases. A number of studies have suggested that such an interplay exists. For example, exposure of cells to HCMV virions is known to induce activation of cellular signal transduction pathways, leading to activation of cellular immediate-early response genes such as c-fos, c-myc, c-jun, and NF-B (3, 4, 96) . Changes in cellular kinase or phosphatase activities upon exposure to HCMV may be involved in viral entry. Keay and Baldwin (43) showed that a 92-kDa HEL cell surface glycoprotein necessary for viral fusion becomes hyperphosphorylated upon exposure to HCMV and mediates increased phosphorylation of cellular proteins through PKC-and tyrosine kinase-mediated pathways. Furthermore, several studies have shown that manipulation of cellular signal transduction pathways near the time of exposure to HCMV can have significant effects on the ability of cells to support HCMV replication (24, 88, 97) , as well as the ability of the IE proteins to function as transcriptional activators (63) . Use of specific kinase inhibitors has been shown to prevent the effects of these pathways on HCMV.
Several studies have suggested that the IE proteins themselves can alter intracellular signaling pathways in order to activate or repress certain promoters. IEP86 has been shown to interact with the tumor suppressors Rb and p53, causing effects on E2F-and p53-responsive elements, respectively (28, 41, 58, 78) . Furthermore, it has been reported that IEP72 interacts with and phosphorylates several members of the E2F and pocket protein families (though not Rb), helping to activate promoters containing E2F elements (52, 60, 69) . In addition, previous work from this laboratory has suggested that some of the IE proteins' transcriptional activation mechanisms reside in an ability to interact with the basal transcription complex, specifically TFIID, and perform a TAF-like function (50) . Clearly, the state of phosphorylation of IEP86 or IEP72 could control the efficacy of this interaction. In fact, data presented in this communication suggests that hypophosphorylation may enhance transcriptional activation of simple promoters by IEP86.
We have examined the role of various cellular kinases in phosphorylating the IE proteins by using an in vitro system in which bacterial IE protein substrates were treated with WCE prepared from either serum-starved or serum-stimulated U-373 MG cells. These studies established that while serumindependent kinases mediated significant phosphorylation, serum-inducible kinases contributed to hyperphosphorylation of IEP86. As an initial step in determining the major phosphorylation sites among the more than 100 serine and threonine residues within IEP86, we incubated a variety of exonic and subexonic fragments of IEP86 with the extracts to define major domains of phosphorylation. The region most strongly phosphorylated was exonic region 5C (amino acids 252 to 367), the major protein-protein interaction domain of IEP86. This region has been shown to be involved in interactions with Rb (19, 77) and transcription factors such as TBP, human TAF II 130, TFIIB, and TEF-1 (9, 49, 50, 77) . Exonic region 5C as well as exonic region 5A (amino acids 85 to 180), another domain involved in protein-protein interactions (50, 77) , were both phosphorylated to similar extents by the serum-starved and the serum-stimulated extracts, suggesting that the phosphorylation sites in these regions may be targeted by kinases which are not affected by serum stimulation.
The in vitro analyses indicated that serum-inducible kinases contribute to hyperphosphorylation of three domains of IEP86: the amino-terminal 85 amino acids common to both IEP86 and IEP72 (exonic region 2/3), an 83-residue domain between positions 175 and 257 (exonic region 5B), and the carboxy-terminal 71 amino acids of IEP86 (exonic region 6). Exonic regions 2/3 and 6 contain acidic domains which function as transcriptional activators when fused to the DNA-binding domain of GAL4 (67, 94) . Regulated phosphorylation of transcription factor activation domains has been shown in many cases to affect their ability to activate transcription (39) . In addition, residues within the exon 2/3 region have been implicated in functional interactions with Rb (19) . Exonic region 5B contains both serine-rich and glutamate-rich motifs. Phosphorylation could add to the negatively charged nature of this region, potentially affecting intramolecular conformation or interactions with other proteins or nucleic acids.
Computer analysis revealed that each of these domains (exonic regions 2/3, 5B, and 6) contains consensus MAPK motifs. MAPK family members such as ERK, JNK-1, and p38 are serine/threonine protein kinases which are induced by serum stimulation of cells (12, 15) . Experiments with purified ERK2 showed that it could phosphorylate IEP86 in vitro. This was most efficient on two of the serum-inducible phosphorylation domains, exon 2/3 and exon 5B. We have preliminary evidence that purified JNK-1 phosphorylates exon 6 efficiently in vitro, as well as exonic regions 2/3 and 5B (not shown).
The predicted phosphorylated residues within four consensus MAPK motifs of IEP86 were targeted for alanine substitution mutagenesis: (i) Thr 27 , found within the acidic activation domain of exonic region 2/3 (67, 94); (ii) Ser 144 , located directly amino terminal to a putative nuclear localization sequence (67) found in the exonic region 5A (Ser 144 also lies within overlapping consensus motifs for both PKC and p34 cdc2 -cyclin B kinase; the number of different kinases which potentially phosphorylate Ser 144 may indicate why in vitro phosphorylation of exonic region 5A appears to be serum independent); (iii) Thr 233 /Ser 234 , adjacent potential sites found within exonic region 5B; and (iv) Thr 555 , within the acidic activation domain of exonic region 6 (67, 94) .
Results of in vitro phosphorylation using WCE showed greatly reduced serum-inducible phosphorylation of substrates containing alanine substitution mutations at Thr 27 and Thr 233 / Ser 234 . This finding indicates that the WT forms of these residues serve as sites for serum-inducible kinases. The level of phosphorylation mediated by serum-starved extracts on mutant substrates was also reduced by these mutations. The simplest explanation for this result is that some residual activity of serum-inducible kinases remains in the serum-starved extracts. In support of this hypothesis, Western analysis for activated forms of ERK1 and ERK2 showed a small amount of activated ERK2 present in the serum-starved extracts (not shown). The evidence that these sites were authentic MAPK sites was supported by the very dramatic reduction of phosphorylation of the alanine-mutant substrates by purified ERK2.
The mutant exonic region 5A, containing the Ala substitution of Ser 144 , displayed no in vitro phosphorylation by either serum-starved or serum-stimulated WCE. This finding suggests that the phosphorylation motif containing Ser 144 is the only phosphorylation site in exonic region 5A recognized by kinases in either serum-starved or serum-stimulated conditions. Preliminary data suggest that purified p34 cdc2 -cyclin B kinase can phosphorylate exonic region 5A on Ser 144 in vitro. Finally, mutation of Thr 555 in exonic region 6 had little effect on the serum-inducible in vitro phosphorylation of exonic region 6, which suggests that a yet to be defined motif in exonic region 6 is the target for serum-inducible kinases. However, preliminary experiments indicate that the Thr 555 mutation does affect the ability of purified JNK-1 to phosphorylate exonic region 6.
The in vivo relevance of these putative phosphorylation sites was demonstrated by two-dimensional tryptic phosphopeptide analysis of WT and mutant forms of IEP86 produced from transfected plasmids. With the exception of Thr 555 , each mutation resulted in the clear loss or alteration of specific phosphopeptides. Interestingly, mutation of Thr 233 /Ser 234 affected phosphorylation of multiple peptides, suggesting that the phosphorylation state of Thr 233 /Ser 234 may alter the conformation of the protein, resulting in effects on phosphorylation at other sites. Moreover, this mutation is the only individual mutation which caused a mobility shift in IEP86 on SDS-PAGE (not shown). Phosphorylation of specific residues in other viral transactivators such as ICP4 and SV40 large T antigen has been shown to influence the phosphorylation of residues located hundreds of amino acids away (10, 73, 93) .
The functional effects of the alanine substitution mutations were tested with respect to transcriptional activation of a simple promoter known to be activated by IEP86 (48, 49) . Somewhat surprisingly, transient transfection analyses showed that IEP86 isoforms with these mutations mediated increased activation of the test promoter relative to the WT protein. Mutation of the MAPK motifs at S 144 and T 233 /S 234 had the greatest effects of single mutations in terms of increased transcriptional activation. Combining the mutations resulted in no greater activity than the mutation at T 233 /S 234 alone. These results suggest that within U-373 MG cells, phosphorylation of WT IEP86 at S 144 and, especially, T 233 /S 234 inhibits transcriptional activation. We reiterate the preceding speculation that phosphorylation at T 233 /S 234 may alter the conformation IEP86. We also note that IEP86 is attributed with a number of other functions which are potentially affected by phosphorylation and remain to be tested.
